These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

117 related articles for article (PubMed ID: 6210721)

  • 1. Viloxazine plasma concentrations and clinical response.
    Norman TR; Burrows GD; Davies BM; Maguire KP; Wurm JM
    J Affect Disord; 1980 Sep; 2(3):157-64. PubMed ID: 6210721
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A clinical and pharmacological study of the antidepressant activity of viloxazine in adult and elderly patients.
    Tosca P; Zerbi F; Romani A; Molini G; Cairoli S; Montagna M; Gabba A; Groppi A
    Int J Clin Pharmacol Ther Toxicol; 1985 May; 23(5):270-3. PubMed ID: 4008117
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Clinical pharmacology of viloxazine hydrochloride.
    Vandel B; Vandel S; Allers G; Volmat R
    Pharmacopsychiatria; 1981 Mar; 14(2):66-70. PubMed ID: 7232498
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Age, therapeutic "milieu" and clinical outcome in depressive patients treated with viloxazine: a study with plasma levels.
    Altamura AC; Mauri MC; Guercetti G
    Prog Neuropsychopharmacol Biol Psychiatry; 1986; 10(1):67-75. PubMed ID: 3704174
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A collaborative study of a new antidepressant, viloxazine, in neurotic and endogenous depressives.
    Guy W; Ban TA; McEvoy JP; Petrie WM; Wilson WH; Schaffer JD
    Int Pharmacopsychiatry; 1982; 17(1):36-42. PubMed ID: 7045017
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Carbamazepine-viloxazine interaction in patients with epilepsy.
    Pisani F; Fazio A; Oteri G; Perucca E; Russo M; Trio R; Pisani B; Di Perri R
    J Neurol Neurosurg Psychiatry; 1986 Oct; 49(10):1142-5. PubMed ID: 3783175
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Multicentre study with viloxazine (Vivalan) in depressed patients.
    Kabes J; Dostal T; Náhunek K; Svestka J; Molcan J; Caplová T; Hynek K; Faltus F; Holland RP
    Int Pharmacopsychiatry; 1980; 15(4):228-39. PubMed ID: 7021448
    [No Abstract]   [Full Text] [Related]  

  • 8. Viloxazine (Vivalan ICI) in depression: results of a field trial of 276 patients in neuropsychiatric practice.
    Sebjanic V; Grombein S
    Adv Biochem Psychopharmacol; 1982; 32():113-20. PubMed ID: 7046360
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Viloxazine in the treatment of endogenous depression. A standard (amitriptyline) controlled clinical study.
    Petrie WM; Ban TA; Wilson WH; Jamieson RC; Guy W
    Int Pharmacopsychiatry; 1982; 17(4):280-6. PubMed ID: 7185772
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Maprotiline in affective illness. Plasma concentration and clinical response.
    Norman TR; Burrows GD; Maguire KP; McIntyre IM; Scoggins BA
    J Affect Disord; 1983 May; 5(2):147-54. PubMed ID: 6222094
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Viloxazine and the depressed schizophrenic--methodological issues.
    Kurland AA; Nagaraju A
    J Clin Pharmacol; 1981 Jan; 21(1):37-41. PubMed ID: 7012190
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Relationship between blood and cerebrospinal levels of the antidepressant agent viloxazine.
    Elwan O; Adam HK
    Eur J Clin Pharmacol; 1980; 17(3):179-82. PubMed ID: 7363931
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Long-term tolerance of viloxazine].
    Brion S; Chevalier JF
    Encephale; 1982; 8(4):511-21. PubMed ID: 7151740
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Viloxazine: an assessment of its potential rapid antidepressant action and unwanted effects.
    Edwards JG
    Curr Med Res Opin; 1977; 5(3):226-33. PubMed ID: 162658
    [No Abstract]   [Full Text] [Related]  

  • 15. Comparison of Vivalan (viloxazine hydrochloride) with imipramine in the treatment of depression. A double-blind study.
    Santonastaso P; Maistrello I; Battistin L
    Acta Psychiatr Scand; 1979 Aug; 60(2):137-43. PubMed ID: 388987
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Chemotherapy of melancholia by sequential neuroleptic-viloxazine association].
    Brion S; Chevalier JF; Guerin R; Ginestet D
    Encephale; 1976; 2(3):257-71. PubMed ID: 991806
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Double-blind trial of sustained-release amitriptyline compared with viloxazine in moderate to severe depressive illness.
    Sedman G
    Curr Med Res Opin; 1977; 5(3):217-25. PubMed ID: 162657
    [No Abstract]   [Full Text] [Related]  

  • 18. Clinical profile and serum concentration of viloxazine as compared to amitriptyline.
    Müller-Oerlinghausen B; Rüther E
    Pharmakopsychiatr Neuropsychopharmakol; 1979 Jul; 12(4):321-37. PubMed ID: 386390
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Clinical trials of viloxazine in depressive states].
    Fontan M; Goudemand M; Pellerin-Millecamps E
    Encephale; 1979; 5(3):243-9. PubMed ID: 385296
    [No Abstract]   [Full Text] [Related]  

  • 20. Recognition of adverse drug reactions in depressed patients treated with viloxazine (Vicilan).
    Maistrello I; Grassi G; Bertolino A; Valerio P; Pistollato G; Soverini S
    Adv Biochem Psychopharmacol; 1982; 32():369-73. PubMed ID: 7090902
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.